Promise and potential pitfalls of anti-VEGF drugs in retinopathy of prematurity

Br J Ophthalmol. 2009 Jul;93(7):986. doi: 10.1136/bjo.2008.156208.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Infant, Newborn
  • Retinopathy of Prematurity / drug therapy*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Vascular Endothelial Growth Factor A